Table 2.
Univariable analysis of attributing factors for 12-month mortality.
| Survival (n = 41,044) |
Death (n = 9506) |
p-Value * | |
|---|---|---|---|
| ICH group, n (%) | 1468 (3.6) | 1099 (11.6) | <0.001 |
| Age, median [25–75th percentile] | 67 [58–74] | 75 [68–79] | <0.001 |
| Sex, n (%) | <0.001 | ||
| Male | 26,148 (63.7) | 5118 (53.8) | |
| Female | 14,896 (36.3) | 4388 (46.2) | |
| Comorbidities, n (%) | |||
| Hypertension | 24,265 (59.1) | 7139 (75.1) | <0.001 |
| Diabetes mellitus | 12,272 (29.9) | 3728 (39.2) | <0.001 |
| Dyslipidemia | 17,380 (42.3) | 4408 (46.4) | <0.001 |
| Acute myocardial infarction | 937 (2.3) | 422 (4.4) | <0.001 |
| Congestive heart failure | 6866 (16.7) | 2914 (30.7) | <0.001 |
| Atrial fibrillation | 5487 (13.4) | 2056 (21.6) | <0.001 |
| Peripheral vascular disease | 6166 (15.0) | 1762 (18.5) | <0.001 |
| Ischemic stroke | 5648 (13.8) | 2009 (21.1) | <0.001 |
| Hemorrhagic stroke | 261 (0.6) | 89 (0.9) | 0.002 |
| Chronic kidney disease | 1009 (2.5) | 575 (6.0) | <0.001 |
| Liver cirrhosis | 353 (0.9) | 124 (1.3) | <0.001 |
| Cancer | 2959 (7.2) | 1236 (13.0) | <0.001 |
| COPD | 2084 (5.1) | 963 (10.1) | <0.001 |
* Wilcoxon rank-sum test was performed for continuous variables. The chi-squared test was used for categorical variables. ICH, intracerebral hemorrhage; COPD, chronic obstructive pulmonary disease.